288 related articles for article (PubMed ID: 19754465)
1. Structure-function studies for the panacea, valproic acid.
Terbach N; Williams RS
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1126-32. PubMed ID: 19754465
[TBL] [Abstract][Full Text] [Related]
2. New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?
Isoherranen N; Yagen B; Bialer M
Curr Opin Neurol; 2003 Apr; 16(2):203-11. PubMed ID: 12644750
[TBL] [Abstract][Full Text] [Related]
3. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
Lampen A; Göttlicher M; Nau H
ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
[TBL] [Abstract][Full Text] [Related]
4. The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior.
Shimshoni JA; Dalton EC; Jenkins A; Eyal S; Ewan K; Williams RS; Pessah N; Yagen B; Harwood AJ; Bialer M
Mol Pharmacol; 2007 Mar; 71(3):884-92. PubMed ID: 17167030
[TBL] [Abstract][Full Text] [Related]
5. Mood stabilizers: protecting the mood...protecting the brain.
Brunello N
J Affect Disord; 2004 Apr; 79 Suppl 1():S15-20. PubMed ID: 15121343
[TBL] [Abstract][Full Text] [Related]
6. New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta).
Lampen A; Siehler S; Ellerbeck U; Göttlicher M; Nau H
Toxicol Appl Pharmacol; 1999 Nov; 160(3):238-49. PubMed ID: 10544058
[TBL] [Abstract][Full Text] [Related]
7. Potent anticonvulsant urea derivatives of constitutional isomers of valproic acid.
Shimshoni JA; Bialer M; Wlodarczyk B; Finnell RH; Yagen B
J Med Chem; 2007 Dec; 50(25):6419-27. PubMed ID: 17994680
[TBL] [Abstract][Full Text] [Related]
8. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
Gravemann U; Volland J; Nau H
Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
[TBL] [Abstract][Full Text] [Related]
9. Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile.
Mishra MK; Kukal S; Paul PR; Bora S; Singh A; Kukreti S; Saso L; Muthusamy K; Hasija Y; Kukreti R
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011339
[TBL] [Abstract][Full Text] [Related]
10. Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure.
Eickholt BJ; Towers GJ; Ryves WJ; Eikel D; Adley K; Ylinen LM; Chadborn NH; Harwood AJ; Nau H; Williams RS
Mol Pharmacol; 2005 May; 67(5):1426-33. PubMed ID: 15687223
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic acid analogues.
Kaufmann D; Bialer M; Shimshoni JA; Devor M; Yagen B
J Med Chem; 2009 Nov; 52(22):7236-48. PubMed ID: 19877649
[TBL] [Abstract][Full Text] [Related]
12. Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect.
Bojic U; Elmazar MM; Hauck RS; Nau H
Chem Res Toxicol; 1996; 9(5):866-70. PubMed ID: 8828922
[TBL] [Abstract][Full Text] [Related]
13. DP-VPA D-Pharm.
Labiner DM
Curr Opin Investig Drugs; 2002 Jun; 3(6):921-3. PubMed ID: 12137414
[TBL] [Abstract][Full Text] [Related]
14. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?
Rosenberg G
Cell Mol Life Sci; 2007 Aug; 64(16):2090-103. PubMed ID: 17514356
[TBL] [Abstract][Full Text] [Related]
15. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
Massa V; Wlodarczyk B; Giavini E; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
[TBL] [Abstract][Full Text] [Related]
16. PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers.
Teo R; King J; Dalton E; Ryves J; Williams RS; Harwood AJ
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1110-4. PubMed ID: 19754462
[TBL] [Abstract][Full Text] [Related]
17. New generation of valproic acid.
Trojnar MK; Wierzchowska-Cioch E; Krzyzanowski M; Jargiełło M; Czuczwar SJ
Pol J Pharmacol; 2004; 56(3):283-8. PubMed ID: 15215557
[TBL] [Abstract][Full Text] [Related]
18. Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: evaluation of the teratogenic effects of its amide derivatives in NMRI mice.
Okada A; Onishi Y; Yagen B; Shimshoni JA; Kaufmann D; Bialer M; Fujiwara M
Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):610-21. PubMed ID: 18671279
[TBL] [Abstract][Full Text] [Related]
19. Diacylglycerol kinase (DGKA) regulates the effect of the epilepsy and bipolar disorder treatment valproic acid in
Kelly E; Sharma D; Wilkinson CJ; Williams RSB
Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30135067
[TBL] [Abstract][Full Text] [Related]
20. Reduced anticonvulsant efficacy of valproic acid in dopamine beta-hydroxylase knockout mice.
Schank JR; Liles LC; Weinshenker D
Epilepsy Res; 2005 Jun; 65(1-2):23-31. PubMed ID: 15955669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
